Delivery Order SPE2DB22D3016-SPE2DB24FATB8
Award Date 4/18/24
Potential Completion Date 5/9/24
Potential Value $4.4K
Federal Agency
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract (SPE2DX15D1053|SPE2DX24F6JDP) valued at $3,509.16 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is for the supply of the pharmaceutical product Zoladex 10.8 mg Implant Syrns to support military treatment programs and facilities. Amerisourcebergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA, valued up to $999,999,999.00...
- The Defense Logistics Agency awarded a delivery order valued at $23,515.44 to AmerisourceBergen Drug Corp for the supply of Zoladex 10.8 mg implant syringes. This firm fixed price contract was competitively awarded without set-aside designation and carries an ultimate completion date of December 22, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the contract at its corporate office location. This delivery order represents a child contract under...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a $11,895.70 firm-fixed-price delivery order contract to AmerisourceBergen Drug Corp's Corporate Office division. This contract is for the supply of ZOLADEX 10.8 MG IMPLANT SYRNS, a pharmaceutical product, with a period of performance through October 21, 2024. AmerisourceBergen is a major pharmaceutical distributor that holds several Indefinite Delivery Contracts (IDCs) with government agencies, including a $999,999,999 IDC...
- This is a delivery order contract awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The $1,249.20 firm fixed price contract is for the delivery of the medication Zoladex 3.6 mg implant syringes, with a completion date of November 5, 2024. Amerisourcebergen provides a broad range of pharmaceutical and medical supplies to federal agencies through various Indefinite Delivery Contracts (IDCs), including a...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract valued at $1,754.58 to Amerisourcebergen Drug Corp, a for-profit pharmaceutical sourcing and distribution company. The contract is for the delivery of ZOLADEX 10.8 MG IMPLANT SYRNS, with a completion date of March 15, 2024. This delivery order is issued under Amerisourcebergen Drug Corp's existing indefinite delivery contract with DLA, which has a potential value of $999,999,999.00 and a performance period...
- The Defense Logistics Agency (DLA) awarded a $18,167.40 firm fixed-price delivery order to Amerisourcebergen Drug Corp (UEI: KABZK8W6PQT3) on January 9, 2026, for the supply of Zoladex 10.8 milligram implant syringes. The contract is non-set-aside and competitively awarded, with performance scheduled for completion by February 2, 2026, at the contractor's facility in Conshohocken, Pennsylvania. Amerisourcebergen Drug Corp operates as a subsidiary of Cencora, Inc. (doing business as...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a for-profit organization and subsidiary of Amerisourcebergen Corporation. The contract is a delivery order valued at $1,873.74 for the supply of ZOLADEX 3.6 MG IMPLANT SYRNS, with a completion date of March 4, 2024. This award is not designated as a set-aside contract. Amerisourcebergen Drug Corp serves as a prime contractor providing a wide range of pharmaceutical products and medical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on January 28, 2026, for the supply of Zoladex 3.6 mg implant syringes, with a ceiling value of $3,592.80. This firm fixed-price delivery order is scheduled for completion by February 19, 2026, and will be performed at the contractor's Conshohocken, Pennsylvania facility. The award was competitively awarded with no set-aside designation, reflecting the contractor's demonstrated capability to meet federal...
- This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading pharmaceutical sourcing and distribution services company. The contract is a delivery order with a firm fixed price valued at $1,561.45, for the supply of ZOLADEX 3.6 MG IMPLANT SYRNS, a specialty pharmaceutical product. The contract has an ultimate completion date of April 24, 2024 and was awarded on April 3,...
- This federal contract award, valued at $1,873.74, was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the delivery of the pharmaceutical product ZOLADEX 3.6 MG IMPLANT SYRNS, with a completion date of May 10, 2024. Amerisourcebergen, a large pharmaceutical distribution company, holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up to...
- SPE2DB22D3016Indefinite Delivery Contract
- SPE2DB22D3016-SPE2DB24FATB8Delivery Order
The U.S. Defense Logistics Agency (DLA) awarded a Delivery Order valued at $4,386.40 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. This Firm Fixed Price contract is for the supply of Zoladex 10.8 mg Implant Syringes, with a completion date of May 9, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999.00 through December 2025, which serves as the primary vehicle for the company to deliver a range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. This contract award did not utilize a set-aside designation.
Generated 7/18/24, 9:38 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.4k | 4/18/24 |